Irsyad Khairil, Arne Scheu and Sheryl Lim have successfully pitched the company "SpyCombinator" in the cancer biotechnology competition Biotarget (https://www.biotarget.org/). During the finals in London on June 11 2019, they competed with seven other finalists from the UK and the USA. The team secured 2nd prize: a $50,000 collaboration with robotic cell culture laboratory Arctoris.
The three DPhil Biochemistry students are currently working with Professor Mark Howarth, who previously spun out the vaccine company SpyBiotech and coordinated the Department's entrepreneurship competition last year. "We believe that the approach SpyCombinator uses can push the discovery of novel drugs for cancer treatment" says co-founder Irsyad Khairil.
24th June 2019